Hutchmed
Clinical trials sponsored by Hutchmed, explained in plain language.
-
New pill tested as last hope for lymphoma patients
Disease control TerminatedThis early-stage study tested a new oral drug called HMPL-523 in adults with lymphoma that had returned or stopped responding to all approved treatments. The main goals were to find a safe dose and see how the body processes the drug. The study was terminated and involved 69 part…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First human test of new cancer pill halted early
Disease control TerminatedThis was an early-stage study to check the safety and find the right dose of an experimental pill called HMPL-306. It was for adults with advanced solid tumors that had a specific genetic change (IDH mutation) and had stopped responding to standard treatments. The study was termi…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug tested for Tough-to-Treat blood cancers
Disease control TerminatedThis study tested a new oral drug called HMPL-306 for adults with advanced blood cancers that have returned, resisted treatment, or not responded to other therapies. The main goals were to find a safe dose and see how the body processes the drug. The trial was for patients whose …
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC